Meanwhile, NFE2L2 is the only one that the intersection of the 56 key targets, ferroptosis regulatory genes and ferroptosis marker in accordance with the FerrDb database, which suggested that ferroptosis may contributes to the pathogenesis of PD, and Nrf2 was regarded as candidate targets of CDG for treating PD. The gene discussed is NFE2L2; the disease is Parkinson disease.